Female Contraception Market Size , Share , Analysis , Forecast , Industry Strategy , Opportunity , Trends , Insights , Growth , Price , Research Survey , Segment , Outlook and Challenges Report To 2016
Female Contraception Market Size , Share , Analysis , Forecast , Industry Strategy , Opportunity , Trends , Insights , Growth , Price , Research Survey , Segment , Outlook and Challenges Report To 2016
Market Reports Center latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception Pipeline Review , H2 2016 , provides an overview of the Female Contraception ( Women ' s Health ) pipeline landscape .
Contraception ( birth control ) prevents pregnancy by interfering with the normal process of ovulation , fertilization , and implantation . There are many contraceptive methods which include implants and injections , intrauterine devices ( IUDs ), pills and vaginal rings , barrier methods , sterilization and natural methods . Contraception generally work by preventing sperm from reaching and fertilizing an egg ( barrier and IUD methods ), preventing an egg from being released every month ( hormones ), blocking the reproductive function ( sterilization ) and preventing a fertilized egg from implanting in the uterus ( hormones ).
Report Highlights
Market Reports Center Pharmaceutical and Healthcare latest pipeline guide Female Contraception – Pipeline Review , H2 2016 , provides comprehensive information on the therapeutics under development for Female Contraception ( Women ' s Health ), complete with analysis by stage of development , drug target , mechanism of action ( MoA ), route of administration ( RoA ) and molecule type . The guide covers the descriptive pharmacological action of the therapeutics , its complete research and development history and latest news and press releases .
To Get Complete Report : https :// marketreportscenter . com / reports / 490761 / femalecontraception-pipeline-review-h2-2016
The Female Contraception ( Women ' s Health ) pipeline guide also reviews of key players involved in therapeutic development for Female Contraception and features dormant and discontinued projects . The guide covers therapeutics under Development by Companies / Universities / Institutes , the molecules developed by Companies in Pre-Registration , Phase III , Phase II , Phase I , Preclinical and Discovery stages are 1 , 6 , 5 , 2 , 6 and 5 respectively . Similarly , the Universities portfolio in Phase III and Preclinical stages comprises 1 and 2 molecules , respectively .